Related Experiment Videos
MHCBN: a comprehensive database of MHC binding and non-binding peptides
Manoj Bhasin1, Harpreet Singh, G P S Raghava
1Institute of Microbial Technology, Chandigarh, India.
Bioinformatics (Oxford, England)
|March 26, 2003
Summary
The Major Histocompatibility Complex Binding and Non-binding (MHCBN) database offers extensive peptide and MHC molecule data. It provides web tools for data analysis and submission, aiding immunological research.
Area of Science:
- Immunoinformatics
- Computational Biology
- Molecular Immunology
Background:
- The Major Histocompatibility Complex (MHC) plays a critical role in the immune system by presenting peptides to T cells.
- Accurate identification of MHC-binding peptides is essential for understanding immune responses and developing therapies.
- Existing databases often lack comprehensive data or integrated analysis tools for MHC-peptide interactions.
Purpose of the Study:
- To present the MHCBN database, a curated repository of MHC binding and non-binding peptides.
- To detail the structure, content, and web-based tools available within the MHCBN database.
- To facilitate research in immunoinformatics and molecular immunology by providing accessible, integrated data.
Main Methods:
- Compilation of MHC binding and non-binding peptide data from published literature and existing databases.
- Inclusion of sequence and structure data for both source proteins and MHC molecules.
- Development of web tools for sequence mapping, data searching, dataset creation, and online submission.
Main Results:
- The latest MHCBN version contains 19,777 entries, including 17,129 MHC binders and 2,648 non-binders.
- Data covers over 400 MHC molecules, with associated sequence and structure information.
- Integrated web tools allow for versatile data exploration and user contributions.
Conclusions:
- MHCBN serves as a valuable, comprehensive resource for researchers studying MHC-peptide interactions.
- The database's integrated tools enhance usability and promote data sharing in the field.
- MHCBN supports advancements in immunology, vaccine design, and immunotherapy development.